Build vs. Buy: Should Your Health System Develop RCM Automation In House?

Your revenue cycle is leaking money. Denial rates are climbing, administrative costs are consuming resources that should go to patient care, and your team is stretched thin. You know automation is the answer. The real question is: should you build it yourself or buy it from a specialized vendor?

It is a question every CIO and CTO in healthcare is facing right now. The appeal of an in house solution is understandable. Full control, no vendor lock in, and customization that fits your workflows exactly. But the reality of building RCM automation internally is far more complex and costly than most technology leaders anticipate.

This guide breaks down both paths with real numbers, real timelines, and a decision framework designed for healthcare technology executives making this choice in 2026.

The Administrative Cost Crisis Driving the Decision

Before weighing the build versus buy tradeoffs, it helps to understand the scale of what is at stake. The 2025 CAQH Index reports that U.S. healthcare avoided an estimated $258 billion in administrative costs in 2024 through electronic transactions and automation. Yet the same report identifies a remaining $21 billion savings opportunity that still exists through full automation of manual and partially manual transactions.

The adoption numbers tell an important story. According to the CAQH research, more than 50 percent of health plans and over 25 percent of provider organizations are already using AI tools in their administrative workflows. The market for RCM automation has matured significantly, which directly impacts your build versus buy calculus. A mature vendor market means proven solutions already exist. Building from scratch means competing against organizations that have spent years refining their technology.

Meanwhile, denial rates continue to strain health system finances. The financial impact of claim denials compounds every month your organization delays action. Whether you build or buy, every week without automation is revenue left on the table.

The Case for Building RCM Automation In House

The argument for building internally has genuine merit, and it deserves honest consideration. Here are the real advantages that attract CIOs and CTOs to the build path.

Complete Control Over the Roadmap

When you build in house, your development priorities align directly with organizational needs. There is no waiting for a vendor's product roadmap to address your specific workflow requirements. If your prior authorization process has unique payer quirks, your team can address them on your timeline.

No Vendor Dependency

Vendor lock in is a legitimate concern. Building internally means you own the code, control the data, and are not subject to a vendor's pricing changes, acquisition events, or service disruptions. This independence resonates strongly with health system leaders who have been through difficult vendor transitions.

Deep Integration with Existing Systems

Your IT team knows your revenue cycle management infrastructure intimately. They understand the specific integration points between your EHR, practice management system, clearinghouses, and payer portals. In theory, this knowledge translates to tighter integration.

These are valid reasons. But they paint an incomplete picture. The decision should not rest on the theoretical advantages of building. It must account for the practical realities.

The Hidden Costs of the Build Path

The gap between the appeal of building and the reality of delivering is where most in house automation projects fall apart. Here is what the build path actually looks like.

Timeline: 12 to 18 Months vs. 6 to 8 Weeks

Building a single RCM automation workflow from scratch, covering requirements gathering, development, testing, compliance validation, and deployment, typically takes 12 to 18 months. That is for one workflow. Most health systems need automation across eligibility verification, prior authorization, claims scrubbing, denial management, payment posting, and revenue reporting.

A specialized vendor with deep RCM domain expertise can deploy individual automation processes in 6 to 8 weeks because the core logic, payer integrations, and compliance frameworks already exist. They have built them, tested them, and refined them across hundreds of implementations.

The Rare Talent Problem

RCM automation requires a rare combination of skills: deep understanding of healthcare revenue cycle workflows, payer rules, compliance requirements, and expertise in automation technologies like RPA and AI. Developers who understand both healthcare billing logic and modern automation architecture are exceptionally difficult to recruit and retain. Senior engineers with this dual skill set command salaries well above $150,000, and they are in high demand across the industry.

Your IT team likely has talented developers. But building RCM automation is not a general software engineering challenge. It requires people who know why a particular CPT code triggers a denial with one payer but not another, and how to programmatically handle those edge cases across hundreds of payer configurations.

Ongoing Maintenance and Payer Rule Updates

Building the automation is only the beginning. Payer rules change constantly. CMS updates reimbursement policies. State regulations shift. Each change requires your team to update, test, and redeploy. What starts as a development project becomes a permanent maintenance burden. Organizations that work with workflow automation partners offload this maintenance entirely, as the vendor absorbs the cost of keeping automation current across all payer environments.

Opportunity Cost: IT Diverted from Strategy

This may be the most significant hidden cost. Every engineering hour spent building RCM automation is an hour not spent on digital health initiatives, telehealth expansion, cybersecurity improvements, or clinical decision support. Your IT team's bandwidth is finite. Using it to build something a specialized vendor has already perfected diverts resources from projects that could deliver far greater strategic value.

Technical Debt Accumulation

In house projects, especially those under time pressure, accumulate technical debt. Shortcuts taken during initial development create long term stability risks. Research published in Procedia Computer Science has shown that healthcare technology projects can experience delays, cost overruns, or failure to meet intended goals in up to 70 percent of cases. Technical debt accelerates this failure trajectory by making each subsequent update harder and riskier.

The Case for Buying or Partnering

The buy path is not simply about convenience. For most health systems, it represents a fundamentally better allocation of resources and a faster path to measurable ROI.

Speed to Value

When your organization is losing revenue to denials, slow payment posting, and manual eligibility checks every single day, the speed advantage of a vendor solution is not just a convenience. It is a financial imperative. A 6 to 8 week deployment means you can begin capturing ROI within the first quarter rather than waiting over a year for your first automated workflow to go live. The cost of RCM inaction now outweighs the cost of implementation for most organizations.

Domain Expertise Built Into the Product

Specialized RCM automation vendors bring decades of revenue cycle expertise into their solutions. This is not generic automation applied to healthcare. It is automation built by people who understand the difference between a CO 4 and a CO 16 denial code and know exactly how each payer handles appeals differently. That domain knowledge is embedded in every workflow rule, exception handler, and reporting dashboard. Organizations with 28+ years of RCM expertise have encountered and solved problems your internal team has not yet discovered.

Shared Risk and Proven Results

When you buy, the vendor shares the implementation risk. They have deployed successfully before and can point to documented case studies with specific performance metrics. When you build, your organization bears 100 percent of the risk if the project runs over budget, misses its timeline, or fails to deliver the expected performance improvements.

Scalability Across Service Lines and EHRs

Established vendors have already solved the integration puzzle across multiple EHR platforms, clearinghouses, and payer portals. Your in house team would need to build and maintain each integration individually. A vendor that operates as an automation layer on top of existing systems can scale across your entire organization without requiring you to replace any current technology.

The Hybrid Overlay Approach: A Third Option

The build versus buy debate often presents a false binary. There is a third approach that combines the best elements of both: the overlay automation model.

In this model, a vendor builds custom automation solutions that layer on top of your existing EHR, practice management, and billing systems. Nothing gets ripped out and replaced. Your current infrastructure stays intact. The automation sits on top, handling the repetitive tasks that consume your team's time while integrating seamlessly with the tools your staff already uses daily.

This approach directly addresses the CIO's concern about vendor lock in. Because the automation is layered rather than embedded, your core systems remain independent. If you ever need to change direction, your foundational infrastructure is unaffected.

It also addresses the customization argument for building in house. The right vendor partner does not sell template software. Instead, they build custom automation solutions tailored to your specific workflows, payer mix, and operational requirements. You get the customization of a build approach with the speed, expertise, and lower risk of a buy approach. This is the model that Innobot Health uses to deliver RPA and AI driven automation across the full revenue cycle.

Build vs. Buy Decision Framework

Use this framework to evaluate which path is right for your organization. Score each factor honestly based on your current situation.

If the "Buy" column resonates more often than the "Build" column, partnering with a specialized vendor is likely the stronger strategic move. For a deeper look at evaluating vendors effectively, explore this guide on choosing an automation partner.

Making the Right Choice for Your Organization

The build versus buy decision is ultimately a question about where your organization's competitive advantage lies. If you are a technology company that happens to operate in healthcare, building may make sense. But if you are a health system whose competitive advantage is clinical excellence and patient care, diverting resources to build technology that specialized vendors have already perfected is unlikely to be the best use of capital or talent.

The healthcare RCM automation market has matured considerably. According to the 2025 CAQH Index, the industry saw a 17 percent increase in administrative cost avoidance through automated transactions last year. This level of industry progress means the question is no longer whether automation works. It does. The question is how quickly you can capture that value for your organization.

For most health systems, the answer involves partnering with a vendor that offers the flexibility of custom built solutions, the speed of proven technology, and the domain expertise of a team that lives and breathes revenue cycle management. Whether you are evaluating the best RPA platform for healthcare or comparing end to end automation solutions, the overlay model gives you the best of both worlds.

Frequently Asked Questions